Search

Search Constraints

You searched for: Author/Creator Iacoboni, Gloria

Search Results

1. Clinical outcome and prognostic factors of patients with Richter syndrome: real‐world study of the Spanish Chronic Lymphocytic Leukemia Study Group (GELLC). (9th June 2020)

2. FC072: Acute Kidney Injury and Chimeric Antigen Receptor (CAR)-T Therapy in Haematologic Neoplasias: The Importance of Kidney Disease. (3rd May 2022)

3. Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial. Issue 18 (20th June 2021)

4. Identifying Early Infections in the Setting of CRS With Routine and Exploratory Serum Proteomics and the HT10 Score Following CD19 CAR-T for Relapsed/Refractory B-NHL. Issue 4 (5th April 2023)

5. Neurotoxicity‐associated sinus bradycardia after chimeric antigen receptor T‐cell therapy. Issue 3 (16th February 2022)

6. Outcome of patients older than 80 years with diffuse large B‐cell lymphoma (DLBCL) treated with "standard" immunochemotherapy: A large retrospective study from 4 institutions. Issue 1 (16th June 2017)

7. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation. Issue 1 (2nd January 2019)

8. Real‐world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B‐cell lymphoma. (1st May 2021)

9. Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center. Issue 9 (29th July 2021)

10. The CAR-HEMATOTOX risk-stratifies patients for severe infections and disease progression after CD19 CAR-T in R/R LBCL. Issue 5 (17th May 2022)